Improving outcomes in gastric cancer over 20 years

Gastric Cancer

Volumn 7, Issue 4, 2004, Pages 196-201

  Desai, Anant M ^a   Pareek, Manish ^b   Nightingale, Peter G ^c   Fielding, John W L ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Gastric cancer; Lymphadenectomy; Sentinel lymph node; Surgery; Survival

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; EARLY DIAGNOSIS; HEALTH CENTER; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; OUTCOMES RESEARCH; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CANCER; SURGEON; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME;

AGED; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 12444276681     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-004-0289-0     Document Type: Article

References (25)

1. Allum WH, Powell DJ, McConkey CC, Fielding JW. Gastric cancer: a 25-year review. Br J Surg 1989;76:535-40.
2. Earle CC, Maroun J, Zuraw L. Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline. Can J Surg 2002;45:438-46.
3. Fielding JW, Fagg SL, Jones BG, Ellis D, Hockey MS, Minawa A, et al. An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group. World J Surg 1983;7:390-9.
4. Hallissey MT, Dunn JA, Ward LC, Allum WH. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: 5-year follow-up. Lancet 1994;343:1309-12.
5. Hermans J, Bonenkamp JJ, Boon MC, Bunt AM, Ohyama S, Sasako M, et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993;11:1441-7.
6. Langman MJ, Dunn JA, Whiting JL, Burton A, Hallissey MT, Fielding JW, et al. Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer. British Stomach Cancer Group. Br J Cancer 1999;81:1356-62.
7. Mackay HJ, McInnes A, Paul J, Raby N, Lofts FJ, Mc Donald AC, et al. A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma. Ann Oncol 2001;12: 1407-10.
8. Allum WH, Hallissey MT, Kelly KA. Adjuvant chemotherapy in operable gastric cancer. Five-year follow-up of first British Stomach Cancer Group trial. Lancet 1989;1:571-4.
9. Hundahl SA, Stemmermann GN, Oishi A. Racial factors cannot explain superior Japanese outcomes in stomach cancer. Arch Surg 1996;131:170-5.
10. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-25.
11. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-8.
12. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 1999;340:908-14.
13. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996;347:995-9.
14. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999;79:1522-30.
15. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
16. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
17. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H. Can sentinel node biopsy indicate rational extent of lymphadenectomy in gastric cancer surgery? Fundamental and new information on lymph-node dissection. Langenbecks Arch Surg 1999;384:149-57.
18. Siewert JR, Kestlmeier R, Busch R, Bottcher K, Rober JD, Muller J, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pNO and pNl lymph node metastases. Br J Surg 1996;83:1144-7.
19. TNM Classification of malignant tumours. 3rd ed. Geneva: UICC-International Union Against Cancer: 1978.
20. Hermanek P, Sobin LH, editors. UICC. TNM Classification of malignant tumours. 4th ed. Berlin Heidelberg New York Tokyo: Springer: 1987.
21. Sobin LH, Wittekind CH, editors. UICC. TNM Classification of malignant tumours. 5th ed. New York: Wiley; 1997.
22. Fielding JW, Roginski C, Ellis DJ, Jones BG, Powell J, Watermouse JA, et al. Clinicopathological staging of gastric cancer. Br J Surg 1984;71:677-80.
23. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1998;1: 10-24.
24. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long-term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002;50:378-81.
25. Bryan RT, Cruickshank NR, Needham SJ, Moffitt DD, Young JA, Hallissey MT, et al. Laparoscopic peritoneal lavage in staging gastric and oesophageal cancer. Eur J Surg Oncol 2001;27:291-7.